BYXTENDIA Trademark

Trademark Overview

On Wednesday, April 29, 2015, a trademark application was filed for BYXTENDIA with the United States Patent and Trademark Office. The USPTO has given the BYXTENDIA trademark a serial number of 86613954. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by AstraZeneca AB. The BYXTENDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
byxtendia

General Information

Serial Number86613954
Word MarkBYXTENDIA
Filing DateWednesday, April 29, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 11, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017EXTENSION 3 GRANTED
Wednesday, October 18, 2017EXTENSION 3 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Friday, April 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2017EXTENSION 2 GRANTED
Tuesday, April 4, 2017EXTENSION 2 FILED
Tuesday, April 4, 2017TEAS EXTENSION RECEIVED
Friday, October 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2016EXTENSION 1 GRANTED
Wednesday, October 5, 2016EXTENSION 1 FILED
Wednesday, October 5, 2016TEAS EXTENSION RECEIVED
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 12, 2016ASSIGNED TO LIE
Tuesday, December 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 16, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 9, 2015NON-FINAL ACTION E-MAILED
Thursday, July 9, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 8, 2015ASSIGNED TO EXAMINER
Monday, May 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 2, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

byxtendia diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal